Cargando…
PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients
Control of transmissible diseases as COVID-19 needs a testing and an isolation strategy. The PARIS score developed by Torjdman et al. was aimed at improving patient selection for testing and quarantining but was derived from a general population. We performed a retrospective analysis of the validity...
Autores principales: | Gueuning, Candice, Ameye, Lieveke, Loizidou, Angela, Grigoriu, Bogdan, Meert, Anne-Pascale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178543/ https://www.ncbi.nlm.nih.gov/pubmed/35678883 http://dx.doi.org/10.1007/s00520-022-07199-9 |
Ejemplares similares
-
Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study
por: Goudsmit, Anouk, et al.
Publicado: (2021) -
ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study
por: Goudsmit, Anouk, et al.
Publicado: (2021) -
Poster: ABCL-013: Factors Associated with SARS-CoV-2 Infection and Outcome in Patients with Solid Tumors or Hematological Malignancies: A Single-Center Study
por: Goudsmit, Anouk, et al.
Publicado: (2021) -
Pre-test probability for SARS-Cov-2-related infection score: The PARIS score
por: Tordjman, Mickael, et al.
Publicado: (2020) -
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
por: Martins-Branco, Diogo, et al.
Publicado: (2022)